1-4 of 4
Allan Louie Cruz, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Updated Results from a Phase I/II Study of Duvelisib and Venetoclax in Patients with Relapsed or Refractory CLL/SLL or Richter's Syndrome

Jennifer L. Crombie, MD, Svitlana Tyekucheva, PhD, Zixu Wang, MS, Alexandra Savell, BS, Lisa Brennan, RN, BSN, Jessica Lowney, Karen Francoeur, RN, Josie Montegaard, NP, Austin I. Kim, MD, Jacob D. Soumerai, MD, Jon E. Arnason, MD, Allan Louie Cruz, MD, Sigrid Berg, MD, David C. Fisher, MD, Jennifer R Brown, MD PhD, Matthew S. Davids, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 46–47.
https://doi.org/10.1182/blood-2020-138811
Published: 2020
Journal Articles

Anticoagulation Therapy Considerations in Left Ventricular Assist Devices in the Setting of Factor VII Deficiency

Anuhya Kommalapati, MD, Sri Harsha Tella, MD, Allan-Louie Cruz, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4898.
https://doi.org/10.1182/blood.V130.Suppl_1.4898.4898
Published: 2017
Journal Articles

Toxicities and Outcomes of Ibrutinib-Treated Patients in the United States: Large Retrospective Analysis of 621 Real World Patients

Anthony R. Mato, MDMSCE, Nicole Lamanna, MD, Chaitra S. Ujjani, MD, Danielle M. Brander, MD, Brian T. Hill, MD PhD, Christina Howlett, PharmD, BCOP, Alan P Skarbnik, MD, Bruce Cheson, MD, Clive S Zent, MD, Jeffrey J Pu, MD PhD, Pavel Kiselev, PhD, Spencer Henick Bachow, MD, Allison M Winter, MD, Allan-Louie Cruz, MD, David F. Claxton, MD, Catherine Daniel, MD, Krista Isaack, DO, Kaitlin H Kennard, BSN, Colleen Timlin, PharmD, Melissa Yacur, MD, Molly Fanning, BS, Lauren E. Strelec, BA, Daniel J. Landsburg, MD, Sunita Dwivedy Nasta, MD, Stephen J. Schuster, MD, David L Porter, MD, Chadi Nabhan, MD MBA, FACP, Paul Barr, MD
Journal: Blood
Blood (2016) 128 (22): 3222.
https://doi.org/10.1182/blood.V128.22.3222.3222
Published: 2016
Journal Articles

Optimal Sequencing of Ibrutinib, Idelalisib, and Venetoclax in CLL: Results from a Large Multi-Center Study of 683 US-Patients

Anthony R. Mato, MD MSCE, Brian T. Hill, MD PhD, Nicole Lamanna, MD, Paul Barr, MD, Chaitra S. Ujjani, MD, Danielle M. Brander, MD, Christina Howlett, PharmD, BCOP, Alan P Skarbnik, MD, Bruce Cheson, MD, Clive S Zent, MD, Jeffrey J Pu, MD PhD, Pavel Kiselev, PhD, Spencer Henick Bachow, MD, Allison M Winter, MD, Allan-Louie Cruz, MD, David F. Claxton, MD, Catherine Daniel, MD, Krista Isaack, DO, Kaitlin H Kennard, BSN, Colleen Timlin, PharmD, Molly Fanning, BS, Melissa Yacur, MD, Jakub Svoboda, MD, Stephen J. Schuster, MD, Chadi Nabhan, MD MBA, FACP
Journal: Blood
Blood (2016) 128 (22): 4400.
https://doi.org/10.1182/blood.V128.22.4400.4400
Published: 2016